Press Release: MicroIslet Implements Staffing Changes to Further the Company's New Corporate Strategy - FierceBiotech - Biotechnology Articles, Biotec

Press Release: MicroIslet Implements Staffing Changes to Further the Company's New Corporate Strategy - FierceBiotech - Biotechnology Articles, Biotech Industry News, FDA Approval News: "As previously announced, MicroIslet has refocused its efforts to accelerate the clinical testing of the Company's ``MicroIslet-P(tm)'' encapsulated islet preparation in persons suffering from Type 1 diabetes. In a first clinical phase, MicroIslet intends to initiate xenograft clinical trials in locations outside of the United States. As part of this strategy, the Company has recently implemented changes to both its management and Board of Directors."